© Copyright 2026 American Medical Association. All rights reserved.
A receptor assay is a laboratory test conducted to evaluate the presence of specific hormone receptors on tumor cells, which can indicate the likelihood of a tumor's response to hormone therapy. The CPT® Code 84235 specifically refers to an endocrine receptor assay that assesses hormones other than estrogen or progesterone. This assay is crucial in oncology, as it helps determine whether certain tumors possess receptors that can bind to hormones circulating in the bloodstream. Hormones play a significant role in cell growth and reproduction, and their interaction with receptors on both normal and cancerous cells can influence tumor behavior. When a tumor is receptor positive for the hormone being tested, it indicates that the tumor has the necessary receptors to respond to hormone therapy, potentially leading to effective treatment options. Conversely, if the tumor is receptor negative, it suggests that the tumor lacks these receptors and is less likely to respond favorably to hormone-based treatments. Understanding the receptor status of a tumor is essential for tailoring appropriate therapeutic strategies and improving patient outcomes.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.